Novartis Czech Republic made a net profit of CZK 71.0 mil in 2017, down 6.08% compared to the previous year. Total sales reached CZK 6,312 mil, which is down 1.25% when compared to the previous year.
Historically, between 2000 and 2017, the company’s net profit reached a high of CZK 82.7 mil in 2015 and a low of CZK 2.15 mil in 2000. Over the last decade the firm's net profit increased by an average of 10.4% a year.
Sales have grown by 3.56% a year on average since 2007. They reached a high of CZK 6,392 mil in 2016 and a low of CZK 1,643 mil in 2000.
The company has been operating with an average EBITDA margin of 2.29% in the last 5 years and average net margin of 1.38%. The firm generated an average return on invested capital of 6.74% for its shareholders over the last five years.
You can see all the company’s data at Novartis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
